Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wolowacz

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Use Of External Data To Guide Long-Term Survival Extrapolations Of Trial Data For Chronic Lymphocytic LeukemiaE Hawe, I Pearson, S Wolowacz, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost-Effectiveness Of Dabigatran Compared With Warfarin, Apixaban, Rivaroxaban And Low Molecular Weight Heparins For The Treatment And Secondary Prevention Of Venous Thromboembolism In ColombiaD Rosselli, J D Rueda, S Wolowacz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 9, 2014
Development and validation of a cost-utility model for Type 1 diabetes mellitusS Wolowacz, I Pearson, P Shannon, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost-Effectiveness of Ofatumumab Plus Chlorambucil in First Line Chronic Lymphocytic Leukemia in CanadaW Herring, I Pearson, M Purser, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Economic Burden of Melanoma in Three European Countries: A Retrospective Observational StudyI Kontoudis, M Harries, P Mohr, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Use Of External Data To Guide Long-Term Survival Extrapolations Of Trial Data For Chronic Lymphocytic LeukemiaE Hawe, I Pearson, S Wolowacz, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost-Effectiveness Of Dabigatran Compared With Warfarin, Apixaban, Rivaroxaban And Low Molecular Weight Heparins For The Treatment And Secondary Prevention Of Venous Thromboembolism In ColombiaD Rosselli, J D Rueda, S Wolowacz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 9, 2014
Development and validation of a cost-utility model for Type 1 diabetes mellitusS Wolowacz, I Pearson, P Shannon, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost-Effectiveness of Ofatumumab Plus Chlorambucil in First Line Chronic Lymphocytic Leukemia in CanadaW Herring, I Pearson, M Purser, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Economic Burden of Melanoma in Three European Countries: A Retrospective Observational StudyI Kontoudis, M Harries, P Mohr, et al.
Pageof 1